It has been demonstrated that the dual inhibition of VEGF and PFKFB3 enhances therapeutic effects against GBM,82 suggesting that targeting glycolysis of ECs might be an effective adjuvant therapy for brain tumours (Figure 3). Here, VEGFA is linked to glioblastoma.